Strong sales of Novo Nordisk’s Wegovy pill helped the company beat first‑quarter earnings expectations and raise its full‑year outlook. CNBC’s Ritika Gupta and Charlotte Reed break down the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results